Hub : Traits :

Sensitivity / hurt feelings

539 significantly associated models · 55 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	52981087	54492569	3	1	1.9e-09	1.1e-08	5.7e-01	99	C1orf123
2	2	147993969	149475737	1	1	3.1e-07	3.9e-08	9.4e-03	78	ORC4
3	7	125383444	127590914	1	1	4.9e-11	4.3e-14	1.9e-06	60	GRM8
4	8	8092025	9669775	6	1	1.4e-09	6.6e-09	1.3e-02	82	FAM86B3P
5	8	10056664	11860845	7	1	7.6e-12	7.5e-11	1.1e-01	94	XKR6
6	8	141421996	142253369	1	1	1.5e-07	4.4e-07	7.8e-01	100	PTK2
7	9	33056378	34496024	1	1	7.2e-08	1.1e-07	4.2e-03	71	PRSS3
8	9	95502571	96898436	1	1	9.2e-09	1.7e-08	4.9e-01	98	RP11-165J3.6
9	9	97520168	98975128	1	1	6.1e-12	1.6e-11	2.3e-01	97	PTCH1
10	11	112950782	113591832	3	4	7.4e-10	8.9e-09	NaN	NaN	ANKK1 DRD2 TTC12
11	12	109231851	110729807	4	1	1.2e-07	7.0e-08	1.0e+00	100	MMAB
12	14	69412804	69954376	1	1	2.1e-07	3.0e-07	5.4e-02	86	EXD2
13	15	90718541	92120170	2	1	3.8e-08	3.2e-08	1.0e+00	100	FURIN
14	17	17484654	18914778	1	1	8.3e-08	4.1e-06	4.5e-03	62	TOP3A
15	17	42413481	45796313	21	1	5.4e-23	1.6e-21	4.3e-01	99	PLEKHM1
16	19	18829733	20313262	1	1	8.3e-08	9.7e-07	9.0e-01	100	GATAD2A

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Neuroticism score	18.4	15	10	22.2	0.97	3.7e-10	ANKK1 C1orf123 DRD2 EXD2 FAM86B3P GRM8 MMAB ORC4 PLEKHM1 PTCH1 PTK2 RP11-165J3.6 TOP3A TTC12 XKR6
Neuroticism (Nagel 2018)	16.5	14	11	24.4	0.98	3.2e-10	ANKK1 C1orf123 DRD2 EXD2 FURIN GRM8 MMAB ORC4 PLEKHM1 PTCH1 PTK2 RP11-165J3.6 TOP3A TTC12
Neuroticism	15.4	13	9	20.0	0.98	2.4e-09	ANKK1 DRD2 EXD2 FURIN GRM8 MMAB ORC4 PLEKHM1 PTCH1 PTK2 RP11-165J3.6 TOP3A TTC12
Depressed Affect (Nagel 2018)	11.5	12	6	13.3	0.98	3.6e-09	ANKK1 DRD2 EXD2 GRM8 MMAB ORC4 PLEKHM1 PTCH1 PTK2 RP11-165J3.6 TOP3A TTC12
Mood swings	10.8	8	6	13.3	0.99	6.8e-07	ANKK1 DRD2 FAM86B3P PLEKHM1 PTK2 RP11-165J3.6 TTC12 XKR6
Worrier / anxious feelings	10.6	7	3	6.7	0.92	3.1e-03	FAM86B3P MMAB ORC4 PLEKHM1 PTCH1 RP11-165J3.6 XKR6
Worry too long after embarrassment	10.6	6	5	11.1	0.96	4.9e-04	ANKK1 DRD2 FAM86B3P PLEKHM1 TTC12 XKR6
Miserableness	10.5	9	6	13.3	0.98	2.3e-07	ANKK1 DRD2 FAM86B3P MMAB ORC4 PLEKHM1 RP11-165J3.6 TTC12 XKR6
Neuroticism (2016)	10.3	6	3	6.7	0.96	2.4e-03	ANKK1 DRD2 FAM86B3P PLEKHM1 TTC12 XKR6
Tense / 'highly strung'	9.6	9	3	6.7	0.99	7.4e-08	ANKK1 C1orf123 DRD2 FAM86B3P ORC4 PTCH1 RP11-165J3.6 TTC12 XKR6
Worry (Nagel 2018)	9.5	8	8	17.8	0.99	6.2e-07	ANKK1 DRD2 MMAB ORC4 PLEKHM1 PTCH1 RP11-165J3.6 TTC12
Irritability	9.5	7	3	6.7	0.96	5.3e-04	ANKK1 DRD2 FAM86B3P MMAB ORC4 PLEKHM1 XKR6
Guilty feelings	9.4	7	4	8.9	0.98	2.0e-05	ANKK1 DRD2 FAM86B3P PLEKHM1 PTCH1 TTC12 XKR6
Nervous feelings	9.3	6	3	6.7	0.96	2.5e-03	ANKK1 FAM86B3P ORC4 PLEKHM1 TTC12 XKR6
Frequency of tenseness / restlessness in last 2 weeks	8.3	7	2	4.4	0.99	1.1e-05	ANKK1 DRD2 MMAB PLEKHM1 RP11-165J3.6 TOP3A TTC12
Fed-up feelings	8.2	9	4	8.9	0.99	8.3e-07	ANKK1 DRD2 EXD2 FAM86B3P ORC4 PLEKHM1 PTK2 TTC12 XKR6
Frequency of tiredness / lethargy in last 2 weeks	7.8	6	3	6.7	0.99	5.0e-05	ANKK1 EXD2 MMAB PTK2 RP11-165J3.6 TTC12
Suffer from 'nerves'	7.6	6	2	4.4	0.99	3.3e-04	ANKK1 DRD2 FAM86B3P PTCH1 TTC12 XKR6
Depression (Nagel 2018)	7.2	5	0	0.0	0.97	1.3e-03	ANKK1 PLEKHM1 RP11-165J3.6 TOP3A TTC12
Frequency of depressed mood in last 2 weeks	6.9	4	0	0.0	1.00	4.2e-03	ANKK1 DRD2 PLEKHM1 RP11-165J3.6
Frequency of unenthusiasm / disinterest in last 2 weeks	6.8	4	0	0.0	1.00	7.8e-05	ANKK1 DRD2 EXD2 TTC12
Seen doctor (GP) for nerves, anxiety, tension or depression	6.3	3	1	2.2	0.00	1.0e+00	ANKK1 DRD2 TTC12
Overall health rating	5.6	5	2	4.4	0.65	1.6e-01	ANKK1 PTK2 RP11-165J3.6 TTC12 XKR6
Hair/balding pattern: Pattern 4	5.3	1	1	2.2	0.00	1.0e+00	PLEKHM1
Loneliness, isolation	5.2	2	0	0.0	0.00	1.0e+00	ORC4 PLEKHM1
Hearing difficulty/problems with background noise	4.9	4	0	0.0	0.99	1.4e-02	ANKK1 MMAB PLEKHM1 TTC12
Schizophrenia (2014)	4.5	4	2	4.4	0.58	4.2e-01	DRD2 FAM86B3P FURIN GATAD2A
High blood pressure	4.4	4	3	6.7	-0.65	3.5e-01	FAM86B3P FURIN TOP3A XKR6
Heel bone mineral density (BMD) T-score, automated (right)	4.4	2	2	4.4	0.00	1.0e+00	FAM86B3P XKR6
Heel bone mineral density (BMD) T-score, automated (left)	4.3	2	2	4.4	0.00	1.0e+00	FAM86B3P XKR6
Headache pain in last month	4.3	1	1	2.2	0.00	1.0e+00	PLEKHM1
Hypertension (Self-reported)	4.3	4	3	6.7	-0.66	3.4e-01	FAM86B3P FURIN TOP3A XKR6
Vascular/heart problems diagnosed by doctor	4.3	4	2	4.4	0.64	3.6e-01	FAM86B3P FURIN TOP3A XKR6
Health satisfaction	4.2	1	0	0.0	0.00	1.0e+00	DRD2
Medication: Blood pressure	4.2	4	3	6.7	-0.94	6.0e-02	FAM86B3P FURIN PLEKHM1 XKR6
Hair/balding pattern: Pattern 3	4.1	1	1	2.2	0.00	1.0e+00	PLEKHM1
Lung FVC	4.0	2	2	4.4	0.00	1.0e+00	PLEKHM1 PTCH1
Systolic blood pressure, automated reading	4.0	4	4	8.9	-0.93	6.7e-02	FAM86B3P FURIN PLEKHM1 XKR6
Financial difficulties in last 2 years	4.0	1	0	0.0	0.00	1.0e+00	DRD2
Seen a psychiatrist for nerves, anxiety, tension or depression	4.0	1	1	2.2	0.00	1.0e+00	C1orf123
Schizophrenia (2018)	3.9	2	1	2.2	0.00	1.0e+00	FURIN GATAD2A
Medication: Bendroflumethiazide	3.9	2	1	2.2	0.00	1.0e+00	FAM86B3P XKR6
Current tobacco smoking	3.7	1	0	0.0	0.00	1.0e+00	EXD2
Forced vital capacity (FVC)	3.7	2	2	4.4	0.00	1.0e+00	PLEKHM1 PTCH1
Bipolar Disorder or Schizophrenia	3.6	3	1	2.2	0.00	1.0e+00	FAM86B3P FURIN GATAD2A
Systolic Blood Pressure	3.5	5	3	6.7	-0.53	3.6e-01	FURIN MMAB PLEKHM1 PTK2 TOP3A
Hearing difficulty/problems: Yes	3.5	2	1	2.2	0.00	1.0e+00	MMAB PTK2
Other serious medical condition/disability diagnosed by doctor	3.5	2	0	0.0	0.00	1.0e+00	ANKK1 TTC12
Medication: Paracetamol	3.5	1	1	2.2	0.00	1.0e+00	PLEKHM1
Forced vital capacity (FVC), Best measure	3.5	3	2	4.4	0.00	1.0e+00	EXD2 PLEKHM1 PTCH1
Impedance of leg (right)	3.4	7	3	6.7	0.15	7.4e-01	FAM86B3P FURIN GATAD2A MMAB PLEKHM1 PTCH1 XKR6
Impedance of leg (left)	3.4	6	4	8.9	0.49	3.3e-01	FAM86B3P FURIN GATAD2A MMAB PLEKHM1 XKR6
Forced expiratory volume in 1-second (FEV1)	3.4	3	2	4.4	0.00	1.0e+00	FAM86B3P PLEKHM1 PTCH1
Long-standing illness, disability or infirmity	3.4	2	0	0.0	0.00	1.0e+00	ANKK1 TTC12
Breast Cancer	3.3	3	2	4.4	0.00	1.0e+00	FURIN GATAD2A PLEKHM1
Number of treatments/medications taken	3.3	1	0	0.0	0.00	1.0e+00	TTC12
Mouth/teeth dental problems	3.3	1	0	0.0	0.00	1.0e+00	PLEKHM1
Peak expiratory flow (PEF)	3.3	3	1	2.2	0.00	1.0e+00	FAM86B3P PLEKHM1 XKR6
Smoking status: Current	3.3	2	0	0.0	0.00	1.0e+00	EXD2 XKR6
Number of operations (self-reported)	3.3	1	0	0.0	0.00	1.0e+00	FURIN
Taking other prescription medications	3.2	1	0	0.0	0.00	1.0e+00	GATAD2A
Hypothyroidism/myxoedema (self-reported)	3.2	2	2	4.4	0.00	1.0e+00	FAM86B3P XKR6
Alcohol intake frequency.	3.2	3	1	2.2	0.00	1.0e+00	DRD2 PLEKHM1 TOP3A
Comparative body size at age 10	3.1	4	3	6.7	-0.99	5.1e-03	FAM86B3P GATAD2A RP11-165J3.6 XKR6
Age at first live birth	3.1	2	0	0.0	0.00	1.0e+00	GATAD2A PLEKHM1
Pain experienced in last month	3.1	3	0	0.0	0.00	1.0e+00	MMAB PLEKHM1 PTK2
Relative age of first facial hair	3.0	1	1	2.2	0.00	1.0e+00	PLEKHM1
Forced expiratory volume in 1-second (FEV1), Best measure	3.0	2	1	2.2	0.00	1.0e+00	PLEKHM1 PTCH1
Wheeze or whistling in the chest in last year	3.0	2	0	0.0	0.00	1.0e+00	ANKK1 RP11-165J3.6
Medication: Blood pressure	3.0	3	0	0.0	0.00	1.0e+00	FURIN TOP3A XKR6
Number of self-reported non-cancer illnesses	3.0	2	0	0.0	0.00	1.0e+00	TOP3A TTC12
Cardiovascular Disease	2.9	5	1	2.2	0.51	3.0e-01	ANKK1 DRD2 FURIN TOP3A TTC12
Impedance of whole body	2.9	4	4	8.9	0.44	5.6e-01	FAM86B3P GATAD2A PLEKHM1 XKR6
Ovarian Cancer	2.8	1	1	2.2	0.00	1.0e+00	PLEKHM1
Medication for cholesterol	2.8	1	0	0.0	0.00	1.0e+00	PLEKHM1
Medication: Paracetamol	2.8	1	1	2.2	0.00	1.0e+00	PLEKHM1
Diastolic blood pressure, automated reading	2.8	3	3	6.7	0.00	1.0e+00	FAM86B3P FURIN XKR6
Blood Red Count	2.7	3	1	2.2	0.00	1.0e+00	DRD2 EXD2 PLEKHM1
Medication: Cholesterol lowering	2.7	2	0	0.0	0.00	1.0e+00	EXD2 GATAD2A
Handedness (chirality/laterality): Left-handed	2.7	2	1	2.2	0.00	1.0e+00	FURIN PLEKHM1
Lupus	2.6	2	0	0.0	0.00	1.0e+00	FAM86B3P XKR6
Birth weight of first child	2.6	1	1	2.2	0.00	1.0e+00	FURIN
Birth weight	2.6	2	2	4.4	0.00	1.0e+00	FURIN PTCH1
Neck or shoulder pain in last month	2.6	2	0	0.0	0.00	1.0e+00	EXD2 PTK2
Leg fat mass (right)	2.6	5	3	6.7	0.21	7.0e-01	ANKK1 EXD2 FAM86B3P TTC12 XKR6
Forced expiratory volume in 1-second (FEV1), predicted percentage	2.6	1	1	2.2	0.00	1.0e+00	PLEKHM1
Leg fat percentage (left)	2.6	5	1	2.2	0.31	5.4e-01	ANKK1 EXD2 FAM86B3P TTC12 XKR6
Ever depressed for a whole week	2.6	1	0	0.0	0.00	1.0e+00	PLEKHM1
HDL Cholesterol	2.5	1	1	2.2	0.00	1.0e+00	MMAB
Medication: Levothyroxine sodium	2.5	2	0	0.0	0.00	1.0e+00	FAM86B3P XKR6
Body mass index (BMI)	2.5	2	2	4.4	0.00	1.0e+00	FAM86B3P XKR6
Father's age at death	2.5	1	0	0.0	0.00	1.0e+00	XKR6
Arm fat mass (right)	2.5	4	2	4.4	0.00	9.9e-01	ANKK1 FAM86B3P TTC12 XKR6
Medication for cholesterol, blood pressure or diabetes	2.5	1	0	0.0	0.00	1.0e+00	FURIN
Leg fat percentage (right)	2.5	5	1	2.2	0.33	5.3e-01	ANKK1 EXD2 FAM86B3P TTC12 XKR6
Mouth/teeth dental problems: Mouth ulcers	2.5	1	1	2.2	0.00	1.0e+00	PLEKHM1
Leg fat mass (left)	2.5	5	3	6.7	0.20	7.0e-01	ANKK1 EXD2 FAM86B3P TTC12 XKR6
Sitting height	2.4	2	2	4.4	0.00	1.0e+00	PLEKHM1 PTCH1
High blood pressure (mother)	2.4	1	1	2.2	0.00	1.0e+00	FURIN
Ever unenthusiastic/disinterested for a whole week	2.4	1	0	0.0	0.00	1.0e+00	PLEKHM1
Impedance of arm (right)	2.4	3	3	6.7	0.00	1.0e+00	FAM86B3P PLEKHM1 XKR6
Number of live births	2.4	2	0	0.0	0.00	1.0e+00	PLEKHM1 TOP3A
Medication for pain relief, constipation, heartburn	2.4	2	1	2.2	0.00	1.0e+00	PLEKHM1 RP11-165J3.6
Relative age voice broke	2.3	1	1	2.2	0.00	1.0e+00	PLEKHM1
Number of incorrect matches in round	2.3	1	1	2.2	0.00	1.0e+00	FURIN
Hair/balding pattern: Pattern 2	2.3	1	1	2.2	0.00	1.0e+00	PLEKHM1
Heart attack	2.3	1	0	0.0	0.00	1.0e+00	FURIN
Arm fat percentage (right)	2.3	5	0	0.0	0.24	6.4e-01	ANKK1 EXD2 FAM86B3P TTC12 XKR6
Impedance of arm (left)	2.3	3	3	6.7	0.00	1.0e+00	FAM86B3P PLEKHM1 XKR6
Body fat percentage	2.3	3	1	2.2	1.00	1.1e-03	ANKK1 EXD2 TTC12
Whole body fat mass	2.3	5	1	2.2	0.29	5.7e-01	ANKK1 EXD2 FAM86B3P TTC12 XKR6
Arm fat mass (left)	2.3	4	2	4.4	-0.02	9.7e-01	ANKK1 FAM86B3P TTC12 XKR6
Average weekly champagne plus white wine intake	2.3	1	0	0.0	0.00	1.0e+00	C1orf123
Waist circumference	2.2	2	2	4.4	0.00	1.0e+00	ANKK1 TTC12
Allergy	2.2	1	0	0.0	0.00	1.0e+00	FURIN
Qualifications: College or University degree	2.2	2	1	2.2	0.00	1.0e+00	EXD2 PLEKHM1
Myopia	2.2	1	0	0.0	0.00	1.0e+00	GATAD2A
Waist Hip Ratio (WHR)	2.1	4	1	2.2	1.00	1.2e-03	ANKK1 PLEKHM1 PTK2 TTC12
Lung FEV1/FVC ratio	2.1	3	1	2.2	0.00	1.0e+00	PLEKHM1 PTCH1 PTK2
Trunk fat percentage	2.1	4	1	2.2	0.39	5.1e-01	ANKK1 EXD2 PLEKHM1 TTC12
Trunk fat mass	2.1	5	1	2.2	0.39	4.4e-01	ANKK1 EXD2 PLEKHM1 TTC12 XKR6
Forced expiratory volume in 1-second (FEV1), predicted	2.1	2	0	0.0	0.00	1.0e+00	PTCH1 TOP3A
Arm fat percentage (left)	2.1	5	1	2.2	0.16	7.6e-01	ANKK1 EXD2 FAM86B3P TTC12 XKR6
Back pain experienced in last month	2.1	1	0	0.0	0.00	1.0e+00	PTK2
Medication: Aspirin	2.1	1	0	0.0	0.00	1.0e+00	FURIN
High cholesterol (Self-reported)	2.1	1	1	2.2	0.00	1.0e+00	GATAD2A
Triglycerides	2.0	1	0	0.0	0.00	1.0e+00	GATAD2A
Blood Eosinophil Count	2.0	4	4	8.9	-0.08	9.2e-01	GATAD2A ORC4 PLEKHM1 TOP3A
Leg fat-free mass (left)	2.0	6	3	6.7	-0.07	8.9e-01	FAM86B3P FURIN GATAD2A MMAB PTCH1 XKR6
Leg predicted mass (left)	2.0	6	3	6.7	-0.08	8.8e-01	FAM86B3P FURIN GATAD2A MMAB PTCH1 XKR6
Leg fat-free mass (right)	2.0	6	4	8.9	-0.07	9.0e-01	FAM86B3P FURIN GATAD2A MMAB PTCH1 XKR6
Leg predicted mass (right)	2.0	6	4	8.9	-0.07	9.0e-01	FAM86B3P FURIN GATAD2A MMAB PTCH1 XKR6
Angina	1.9	1	1	2.2	0.00	1.0e+00	FURIN
Weight	1.9	4	1	2.2	-0.01	9.8e-01	ANKK1 FAM86B3P TTC12 XKR6
Medication: Ibuprofen (e.g. Nurofen)	1.9	1	0	0.0	0.00	1.0e+00	PLEKHM1
Average weekly beer plus cider intake	1.9	1	0	0.0	0.00	1.0e+00	XKR6
Verbal and Numeric Reasoning (VNR)	1.8	1	0	0.0	0.00	1.0e+00	PLEKHM1
Age when periods started (menarche)	1.8	1	0	0.0	0.00	1.0e+00	PLEKHM1
Hip circumference	1.8	5	1	2.2	0.14	7.9e-01	ANKK1 FAM86B3P PTCH1 TTC12 XKR6
Angina (self-reported)	1.8	1	0	0.0	0.00	1.0e+00	FURIN
Smoking Status	1.7	1	0	0.0	0.00	1.0e+00	EXD2
Hand grip strength (left)	1.7	1	1	2.2	0.00	1.0e+00	PLEKHM1
Whole body fat-free mass	1.7	5	2	4.4	-0.15	8.1e-01	FAM86B3P GATAD2A MMAB PTCH1 XKR6
Whole body water mass	1.7	5	2	4.4	-0.16	8.0e-01	FAM86B3P GATAD2A MMAB PTCH1 XKR6
Basal metabolic rate	1.7	5	2	4.4	-0.18	7.7e-01	FAM86B3P GATAD2A MMAB PTCH1 XKR6
Intelligence (Savage-Jansen 2018)	1.6	1	0	0.0	0.00	1.0e+00	PLEKHM1
Qualifications: A levels/AS levels or equivalent	1.6	1	0	0.0	0.00	1.0e+00	PLEKHM1
Arm fat-free mass (left)	1.6	3	1	2.2	0.00	1.0e+00	FAM86B3P PTCH1 XKR6
Arm predicted mass (left)	1.6	3	2	4.4	0.00	1.0e+00	FAM86B3P PTCH1 XKR6
BMI	1.5	4	1	2.2	1.00	4.6e-05	ANKK1 EXD2 MMAB TTC12
Medication: Atenolol	1.5	1	0	0.0	0.00	1.0e+00	FURIN
Trunk fat-free mass	1.5	3	1	2.2	0.00	1.0e+00	GATAD2A PTCH1 XKR6
Trunk predicted mass	1.5	3	1	2.2	0.00	1.0e+00	GATAD2A PTCH1 XKR6
Arm fat-free mass (right)	1.5	3	1	2.2	0.00	1.0e+00	FAM86B3P PTCH1 XKR6
Arm predicted mass (right)	1.5	3	1	2.2	0.00	1.0e+00	FAM86B3P PTCH1 XKR6
Comparative height size at age 10	1.5	3	1	2.2	0.37	6.3e-01	ANKK1 PLEKHM1 PTCH1
Primary Biliary Cirrhosis	1.4	1	0	0.0	0.00	1.0e+00	PLEKHM1
Hand grip strength (right)	1.4	1	1	2.2	0.00	1.0e+00	PLEKHM1
Fluid intelligence score	1.4	1	0	0.0	0.00	1.0e+00	PLEKHM1
Blood Platelet Count	1.3	2	1	2.2	0.00	1.0e+00	GATAD2A PTK2
Fractured/broken bones in last 5 years	1.3	1	0	0.0	0.00	1.0e+00	PLEKHM1
Standing height	1.2	5	2	4.4	0.56	3.2e-01	FAM86B3P PLEKHM1 PTCH1 RP11-165J3.6 TOP3A
Blood White Count	1.1	4	2	4.4	-0.02	9.8e-01	FURIN PLEKHM1 PTCH1 TTC12
Heel T-Score	1.0	1	1	2.2	0.00	1.0e+00	PLEKHM1
Height	1.0	5	4	8.9	0.53	3.6e-01	FURIN PLEKHM1 PTCH1 RP11-165J3.6 TOP3A

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Uterus	8	1.411	2.4
GTEx	Small Intestine Terminal Ileum	6	1.302	2.3
GTEx	Artery Coronary	10	0.845	2.2
GTEx	Brain Cortex	7	0.676	2.1
GTEx	Brain Frontal Cortex BA9	6	0.649	2.1
GTEx	Brain Hippocampus	4	0.763	2.1
GTEx	Brain Hypothalamus	4	0.678	2.1
GTEx	Brain Nucleus accumbens basal ganglia	7	0.809	2.1
GTEx	Brain Putamen basal ganglia	5	0.801	2.1
GTEx	Ovary	8	0.881	2.1
GTEx	Vagina	6	0.945	2.1
GTEx	Brain Cerebellar Hemisphere	9	0.604	2.0
GTEx	Breast Mammary Tissue (Male)	7	0.587	2.0
GTEx	Cells EBV-transformed lymphocytes	12	0.843	2.0
GTEx	Esophagus Gastroesophageal Junction	9	0.623	2.0
GTEx	Heart Left Ventricle	10	0.654	2.0
GTEx	Liver	5	0.697	2.0
GTEx	Pancreas	10	0.613	2.0
GTEx	Stomach	7	0.481	2.0
GTEx	Artery Aorta	14	0.470	1.9
GTEx	Brain Caudate basal ganglia	4	0.435	1.9
GTEx	Brain Cerebellum	7	0.353	1.9
GTEx	Breast Mammary Tissue (Female)	13	0.791	1.9
GTEx	Colon Sigmoid	10	0.684	1.9
GTEx	Colon Transverse	12	0.581	1.9
GTEx	Esophagus Muscularis	14	0.433	1.9
GTEx	Heart Atrial Appendage	9	0.570	1.9
GTEx	Pituitary	7	0.628	1.9
GTEx	Prostate	6	0.719	1.9
GTEx	Spleen	10	0.709	1.9
GTEx	Adipose Visceral Omentum	11	0.540	1.8
GTEx	Adrenal Gland	9	0.618	1.8
GTEx	Breast Mammary Tissue	11	0.557	1.8
GTEx	Esophagus Mucosa	15	0.452	1.8
GTEx	Lung	13	0.452	1.8
GTEx	Muscle Skeletal	11	0.381	1.8
GTEx	Skin Not Sun Exposed Suprapubic	12	0.488	1.8
GTEx	Skin Sun Exposed Lower leg	12	0.330	1.8
GTEx	Testis	11	0.349	1.8
GTEx	Thyroid	14	0.350	1.8
GTEx	Adipose Subcutaneous	9	0.258	1.7
GTEx	Artery Tibial	7	0.186	1.7
GTEx	Cells Transformed fibroblasts	11	0.262	1.7
GTEx	Nerve Tibial	10	0.231	1.7
GTEx	Whole Blood	8	0.401	1.7
NTR	Blood	4	0.167	1.7
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	4	0.242	1.7
The Cancer Genome Atlas	Esophageal Carcinoma	3	0.438	1.7
The Cancer Genome Atlas	Glioblastoma Multiforme	4	0.391	1.7
The Cancer Genome Atlas	Soft Tissue Sarcoma	3	0.281	1.7
ROSMAP	Brain Pre-frontal Cortex	8	0.182	1.6
CommonMind	Brain Pre-frontal Cortex	7	0.130	1.6
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	3	0.273	1.6
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	5	0.184	1.6
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	7	0.171	1.6
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	5	0.244	1.6
The Cancer Genome Atlas	Brain Lower Grade Glioma	5	0.116	1.6
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	4	0.362	1.6
The Cancer Genome Atlas	Lung Adenocarcinoma	8	0.272	1.6
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	6	0.239	1.6
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	4	0.251	1.6
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	4	0.241	1.6
The Cancer Genome Atlas	Prostate Adenocarcinoma	9	0.195	1.6
The Cancer Genome Atlas	Stomach Adenocarcinoma	3	0.178	1.6
The Cancer Genome Atlas	Testicular Germ Cell Tumors	5	0.391	1.6
The Cancer Genome Atlas	Thyroid Carcinoma	9	0.174	1.6
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	2	0.394	1.6
METSIM	Adipose	1	0.022	1.5
YFS	Blood	2	0.043	1.5
The Cancer Genome Atlas	Breast Invasive Carcinoma	5	0.113	1.5
The Cancer Genome Atlas	Colon Adenocarcinoma	2	0.097	1.5
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	4	0.301	1.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	2	0.289	1.5
The Cancer Genome Atlas	Skin Cutaneous Melanoma	1	0.187	1.4